These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 13222863
1. Heart-failure from retention of salt and water caused by treatment with pentapyrrolidinium bitartrate. RØNNOV-JESSEN V. Lancet; 1955 Jan 15; 268(6855):122-4. PubMed ID: 13222863 [No Abstract] [Full Text] [Related]
2. Fluid retention during methonium therapy. FRASER JR, LOWE TE. Australas Ann Med; 1954 Aug 15; 3(3):234-7. PubMed ID: 13198779 [No Abstract] [Full Text] [Related]
3. Congestive heart failure in rheumatic heart disease; toxic action of salt. MENEELY GR. Trans Am Coll Cardiol; 1956 Jun 15; 6(1):102-9. PubMed ID: 13380927 [No Abstract] [Full Text] [Related]
4. A case of intestinal obstruction following the administration of pentapyrrolidinium bitartrate (ansolysen). GIBSON DS. Med J Aust; 1957 Dec 14; 44(24):860-1. PubMed ID: 13492801 [No Abstract] [Full Text] [Related]
5. [Treatment of arterial hypertension with M & B 2050A (pentapyrrolidinium bitartrate)]. FERNANDEZ FERRER O, MACIAS CASTRO I, LOPEZ DE LA VEGA R. Arch Hosp Univ; 1955 Dec 14; 7(2):113-9. PubMed ID: 13269266 [No Abstract] [Full Text] [Related]
6. [Drug therapy of arterial hypertension; pentapyrrolidinium bitartrate (ansolysen), a new remedy for peroral use]. RØNNOV-JESSEN V. Ugeskr Laeger; 1954 Apr 15; 116(15):551-8. PubMed ID: 13169361 [No Abstract] [Full Text] [Related]
9. Permanent bilateral blindness following the use of hexamethonium chloride. BRUCE GM. AMA Arch Ophthalmol; 1955 Sep 15; 54(3):422-4. PubMed ID: 13248304 [No Abstract] [Full Text] [Related]
10. Renal haemodynamic effects of hypotensive drugs. II. Effects of oral maintenance therapy with pentapyrrolidinium bitartrate and reserpine. GOLDBERG B, MCDONALD L. Lancet; 1957 Jan 12; 272(6959):77-8. PubMed ID: 13386279 [No Abstract] [Full Text] [Related]
12. Hematuria during treatment of severe hypertension with hexamethonium bromide and pentolinium tartrate. MCCLOSKEY BJ. J Fla Med Assoc (1914); 1955 Oct 12; 42(4):278-9. PubMed ID: 13263500 [No Abstract] [Full Text] [Related]
13. Lithium intoxication occurring with the use of a table salt substitute in the low sodium dietary treatment of hypertension and congestive heart failure. WALDRON AM. Univ Hosp Bull; 1949 Feb 12; 15(2):9. PubMed ID: 18117430 [No Abstract] [Full Text] [Related]
14. Mechanisms of salt and water retention in congestive heart failure. The importance of aldosterone. DAVIS JO. Am J Med; 1960 Sep 12; 29():486-507. PubMed ID: 13720203 [No Abstract] [Full Text] [Related]
16. The effects of chronic pentapyrrolidinium-induced hypotension on renal hemodynamics and on the excretion of water and electrolytes in hypertension. STOVER JW, GRIFFIN RW, FORD RV. Ann Intern Med; 1956 May 12; 44(5):893-8. PubMed ID: 13314409 [No Abstract] [Full Text] [Related]
17. The effect of sulfanilamide on salt and water excretion in congestive heart failure. SCHWARTZ WB. N Engl J Med; 1949 Feb 03; 240(5):173-7. PubMed ID: 18108079 [No Abstract] [Full Text] [Related]
18. Salt and water excretion in heart failure. THOMPSON DD. Prog Cardiovasc Dis; 1961 May 03; 3():520-36. PubMed ID: 13776560 [No Abstract] [Full Text] [Related]
19. [Treatment of hypertension with 3-methyl-pentapyrrolidinium]. MOELLER J. Med Klin; 1956 Aug 31; 51(35):1466-71. PubMed ID: 13358552 [No Abstract] [Full Text] [Related]
20. [Consequence of a salt diet: heart strain]. TROCME C. Arch Mal Coeur Vaiss; 1951 Jul 31; 44(7):655-68. PubMed ID: 14878489 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]